ArticleAdvanced healthcare materials2025
Biofabrication of a Filtration Barrier by Integrating Electrospun Membranes and Flow in a Glomerular Co-Culture.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Muscle-fiber-inspired nanofibrillar microbundles induce myogenic differentiation in human adipose-derived stem cells.Bioactive materials · 2026Article
- Construction, evaluation, and applications of renal barrier-on-a-chip system.Bioactive materials · 2026Review
- Bioprinting Organs-Science or Fiction?-A Review From Students to Students.Advanced healthcare materials · 2026Review
- New Dimensions in Diabetic Kidney Disease Research: Advanced Organoids and Organs-on-a-Chip.BME frontiers · 2026Review
- Bioassembly of Myoblast Spheroids in Electrofibrillated Scaffolds for 3D Muscle Tissue Biofabrication.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
- Biofabrication of a Filtration Barrier by Integrating Electrospun Membranes and Flow in a Glomerular Co-Culture.Advanced healthcare materials · 2025Article
- Specificity of endothelial cells in endothelial dysfunction of diabetic kidney disease and their crosstalk with neighboring cells: an updated review.Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The glomerular filtration barrier (GFB), composed of glomerular endothelial cells, podocytes, and the glomerular basement membrane (GBM), is essential for selective filtration in the kidney. Damage to any GFB component results in proteinuria and kidney failure. To model glomerular pathophysiology and test therapies, this study introduces an ex vivo GFB model using electrospun poly-L-lactic acid fibers that mimic the GBM. The fibers are functionalized with polydopamine and gelatin, then seeded with human glomerular endothelial cells and podocytes on opposite sides. This biomimetic setup supports monolayer formation, cell-type-specific marker expression, and appropriate morphology of both cell types, including those derived from human induced pluripotent stem cells (hiPSCs). The model demonstrates bidirectional cell-cell communication across the membrane. Permeability assays confirm size-selective dextran filtration. Under flow conditions in a custom 3D-printed micro-bioreactor, endothelial cells develop fenestrae-like structures, whereas podocytes form foot process-like extension features, which are often lacking in static in vitro systems. This platform replicates critical features of the native GFB and provides a robust system for studying glomerular function, disease mechanisms, and therapeutic responses. Moreover, incorporating hiPSC-derived podocytes enables exploration of patient-specific mutations and personalized treatment strategies in kidney disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.